A global perspective on sickle cell disease
Pediatric Blood & Cancer2012Vol. 59(2), pp. 386–390
Citations Over TimeTop 10% of 2012 papers
Abstract
The global burden of sickle cell disease (SCD) is now being increasingly realized. SCD poses a significant public health problem in sub-Saharan Africa, the Middle East, some regions of India, the Caribbean, and Brazil. In many of these regions, progress in the management of SCD has been slow. Long-term North-South and South-South partnerships between SCD professionals, funding agencies, governments, and industry are needed to help reduce the high disease burden in developing countries, through widespread SCD education, relevant research and implementation of evidence-based cost-effective interventions. A group of SCD professionals have responded with action by forming a global network.
Related Papers
- → The Australian Burden of Disease Study: measuring the loss of health from diseases, injuries and risk factors(2000)346 cited
- → THE PREVALENCE AND BURDEN OF MENTAL AND SUBSTANCE USE DISORDERS IN ROMANIA: FINDINGS FROM THE GLOBAL BURDEN OF DISEASE STUDY 2016(2019)10 cited
- Updated Estimates of Burden Due to Mental and Substance Use Disorders from the Global Burden of Disease Study 2013(2015)
- → Trends in the Burden of Obesity-Related Cancers in SADC Countries, 1990-2019: Findings from the Global Burden of Disease Study(2023)
- National Burden of Eye Diseases in Iran 1990-2010; Findings from the Global Burden of Disease Study 2010(2014)